Results 281 to 290 of about 262,635 (315)
Some of the next articles are maybe not open access.
Treatment of chronic hepatitis B
Journal of Viral Hepatitis, 1994SUMMARY.Chronic infection with the hepatitis B virus (HBV) is a major cause of worldwide morbidity and mortality. A large number of therapeutic approaches has been tried, including interferon (IFN), nucleoside analogues and immunomodulators. To date controlled clinical trials have shown that only IFN is of long‐term value but many patients fail to ...
openaire +3 more sources
The association of chronic hepatitis B and myopathy
Neurology, 2006In two patients with chronic hepatitis B and myopathy, muscle biopsy showed necrosis and scarce inflammatory infiltrates. CD8+ cells surrounded some non-necrotic fibers. Hepatitis B virus (HBV) DNA and antigens were found inside intact muscle fibers. Major histocompatibility complex class I antigens were coexpressed with viral antigens. In one patient,
CAPASSO M +8 more
openaire +5 more sources
The management of chronic hepatitis B
The American Journal of Medicine, 1994The immediate goals of hepatitis B virus (HBV) therapy are to suppress the histologic progression of the disease and diminish infectivity. Although many drugs have been used in the treatment of this condition, only interferon has proven to be consistently effective.
openaire +3 more sources
Lamivudine for chronic hepatitis B
Expert Review of Anti-infective Therapy, 2004Lamivudine (Epivir, GlaxoSmithKline) was approved by the US Food and Drug Administration for the treatment of adult patients with chronic hepatitis B in 1998, and has since been shown to be of benefit to selected patients with chronic hepatitis B. Drug resistance is the main issue encountered during therapy, with lamivudine resistant mutants emerging ...
openaire +3 more sources
Entecavir for chronic hepatitis B
2007Reason for withdrawal from publication This review protocol is withdrawn as it is replaced by a new, updated protocol with the same title. The new published protocol is prepared by another team of authors as follows: Ismail MH, Wiysonge CS, Ricaforte-Campos JD, Clarke MJ.
Murray Krahn, Sean Prichett, Gloria Woo
openaire +2 more sources
Treatment of Chronic Hepatitis B and Chronic Hepatitis C
Reviews in Medical Virology, 1996openaire +3 more sources
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Harrys A Torres +2 more
exaly
The importance of immunization in cancer prevention, treatment, and survivorship
Ca-A Cancer Journal for Clinicians, 2017Ted Gansler +2 more
exaly